Previous studies on CT83 expression in cancer showed similar results; CT83 is highly expressed in gastric,27 28 triple-negative breast,29 and non-small cell lung cancer.30 This bioinformatics analysis and experimental studies have demonstrated that CT83 is one of the most suitable targets for solid cancers. The gene discussed is CT83; the disease is non-small cell lung carcinoma.